{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:07:14Z","timestamp":1791619634044,"version":"4.3.4"},"reference-count":117,"publisher":"Georg Thieme Verlag KG","issue":"04","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P50AA024333"],"award-info":[{"award-number":["P50AA024333"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01AA026398"],"award-info":[{"award-number":["U01AA026398"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>This review aims to summarize recent research using animal models, cell models, and human data regarding the role of complement in liver disease. Complement is part of the innate immune system and was initially characterized for its role in control of pathogens. However, evidence now indicates that complement also plays an important role in the response to cellular injury that is independent of pathogens. The liver is the main organ responsible for producing circulating complement. In response to liver injury, complement is activated and likely plays a dual role, both contributing to and protecting from injury. In uncontrolled complement activation, cell injury and liver inflammation occur, contributing to progression of liver disease. Complement activation is implicated in the pathogenesis of multiple liver diseases, including alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease, fibrosis and cirrhosis, hepatocellular carcinoma, and autoimmune hepatitis. However, the mechanisms by which complement is overactivated in liver diseases are still being unraveled.<\/jats:p>","DOI":"10.1055\/s-0044-1795143","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:19:08Z","timestamp":1732839548000},"page":"510-522","source":"Crossref","is-referenced-by-count":12,"title":["Role of Complement in Liver Diseases"],"prefix":"10.1055","volume":"44","author":[{"given":"Luan G.","family":"Prado","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Nagy","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio"},{"name":"Department of Molecular Medicine, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"e2250042","DOI":"10.1002\/eji.202250042","article-title":"Complement, complosome, and complotype: a perspective","volume":"53","author":"P Singh","year":"2023","journal-title":"Eur J Immunol"},{"issue":"07","key":"ref2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41581-023-00704-1","article-title":"Complosome - the intracellular complement system","volume":"19","author":"E E West","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1146167","DOI":"10.3389\/fimmu.2023.1146167","article-title":"The role of the complosome in health and disease","volume":"14","author":"F Xiao","year":"2023","journal-title":"Front Immunol"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4049\/jimmunol.2200540","article-title":"Complement: the road less traveled","volume":"210","author":"C Kemper","year":"2023","journal-title":"J Immunol"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/JLB.3MIR0220-270R","article-title":"Complement: bridging the innate and adaptive immune systems in sterile inflammation","volume":"108","author":"M W Lo","year":"2020","journal-title":"J Leukoc Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.imlet.2016.07.014","article-title":"The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease model","volume":"177","author":"L Bavia","year":"2016","journal-title":"Immunol Lett"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"102534","DOI":"10.1016\/j.autrev.2020.102534","article-title":"The role of complement activation in autoimmune liver disease","volume":"19","author":"M Biewenga","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"100324","DOI":"10.1016\/j.jhepr.2021.100324","article-title":"The role of cGAS-STING signalling in liver diseases","volume":"3","author":"R Chen","year":"2021","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.gastro.2010.04.041","article-title":"Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice","volume":"139","author":"J I Cohen","year":"2010","journal-title":"Gastroenterology"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2007.01.053","article-title":"Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice","volume":"132","author":"M T Pritchard","year":"2007","journal-title":"Gastroenterology"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/hep.22776","article-title":"An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice","volume":"49","author":"S Roychowdhury","year":"2009","journal-title":"Hepatology"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.23228","article-title":"Activation of the complement system in human nonalcoholic fatty liver disease","volume":"50","author":"S S Rensen","year":"2009","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"23279","DOI":"10.1038\/srep23279","article-title":"Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population","volume":"6","author":"C Xu","year":"2016","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1054159","DOI":"10.3389\/fimmu.2022.1054159","article-title":"Association of complement components with the risk and severity of NAFLD: a systematic review and meta-analysis","volume":"13","author":"J Zhao","year":"2022","journal-title":"Front Immunol"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/aqaa147","article-title":"Recurrent autoimmune hepatitis and de novo autoimmune hepatitis in the liver allograft","volume":"155","author":"I A Gonz\u00e1lez","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"100497","DOI":"10.1016\/j.jhepr.2022.100497","article-title":"Circulating complement factor H levels are associated with disease severity and relapse in autoimmune hepatitis","volume":"4","author":"M Hayashi","year":"2022","journal-title":"JHEP Rep Innov Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1533033820970668","DOI":"10.1177\/1533033820970668","article-title":"Down-regulation of C3aR\/C5aR inhibits cell proliferation and EMT in hepatocellular carcinoma","volume":"19","author":"B Chen","year":"2020","journal-title":"Technol Cancer Res Treat"},{"issue":"08","key":"ref18","first-page":"4039","article-title":"Complement factor H-deficient mice develop spontaneous hepatic tumors","volume":"130","author":"J Laskowski","year":"2020","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.toxlet.2020.08.014","article-title":"Aristolochic acid I promotes the invasion and migration of hepatocellular carcinoma cells by activating the C3a\/C3aR complement system","volume":"378","author":"Y Li","year":"2023","journal-title":"Toxicol Lett"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/cr60104a001","article-title":"Recent advances in the chemistry of complement","volume":"33","author":"L Pillemer","year":"1943","journal-title":"Chem Rev"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.imbio.2016.06.011","article-title":"Complement research in the 18th-21st centuries: progress comes with new technology","volume":"221","author":"R B Sim","year":"2016","journal-title":"Immunobiology"},{"issue":"S 04","key":"ref22","first-page":"S5","article-title":"Complement biology for hematologists","volume":"98","author":"A Duval","year":"2023","journal-title":"Am J Hematol"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"P F Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"M Noris","year":"2013","journal-title":"Semin Nephrol"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00281-017-0644-y","article-title":"Complement as a regulator of adaptive immunity","volume":"40","author":"J Killick","year":"2018","journal-title":"Semin Immunopathol"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"R Lubbers","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"09","key":"ref27","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2215\/CJN.06230614","article-title":"Molecules great and small: the complement system","volume":"10","author":"D R Mathern","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A journey through the lectin pathway of complement-MBL and beyond","volume":"274","author":"P Garred","year":"2016","journal-title":"Immunol Rev"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/liv.12682","article-title":"Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure","volume":"35","author":"T L Laursen","year":"2015","journal-title":"Liver Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fimmu.2018.00764","article-title":"Complement component C1q: historical perspective of a functionally versatile, and structurally unusual, serum protein","volume":"9","author":"K BM Reid","year":"2018","journal-title":"Front Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.imlet.2021.05.007","article-title":"Complement system in alcohol-associated liver disease","volume":"236","author":"L E Santiesteban-Lores","year":"2021","journal-title":"Immunol Lett"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3389\/fimmu.2018.02238","article-title":"Development of a quantitative assay for the characterization of human collectin-11 (CL-11, CL-K1)","volume":"9","author":"R Bayarri-Olmos","year":"2018","journal-title":"Front Immunol"},{"issue":"6292","key":"ref33","doi-asserted-by":"crossref","first-page":"aad1210","DOI":"10.1126\/science.aad1210","article-title":"T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells","volume":"352","author":"G Arbore","year":"2016","journal-title":"Science"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.31419","article-title":"Diagnostic and prognostic significance of complement in patients with alcohol-associated hepatitis","volume":"73","author":"X Fan","year":"2021","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3389\/fimmu.2019.00752","article-title":"Complement C5b-9 and cancer: mechanisms of cell damage, cancer counteractions, and approaches for intervention","volume":"10","author":"Z Fishelson","year":"2019","journal-title":"Front Immunol"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000233475","article-title":"Structural insights into the recognition properties of human ficolins","volume":"2","author":"V Garlatti","year":"2010","journal-title":"J Innate Immun"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"152410","DOI":"10.1016\/j.imbio.2023.152410","article-title":"Complement factor I: regulatory nexus, driver of immunopathology, and therapeutic","volume":"228","author":"T M Hallam","year":"2023","journal-title":"Immunobiology"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/imr.13132","article-title":"Alternative pathway activation: ever ancient and ever new","volume":"313","author":"M K Liszewski","year":"2023","journal-title":"Immunol Rev"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/imr.13156","article-title":"Alternative pathway diagnostics","volume":"313","author":"J M Thurman","year":"2023","journal-title":"Immunol Rev"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/imr.13143","article-title":"Low-molecular weight inhibitors of the alternative complement pathway","volume":"313","author":"A Schubart","year":"2023","journal-title":"Immunol Rev"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41589-023-01339-w","article-title":"Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins","volume":"19","author":"Y Wang","year":"2023","journal-title":"Nat Chem Biol"},{"issue":"66","key":"ref42","doi-asserted-by":"crossref","first-page":"eabf2489","DOI":"10.1126\/sciimmunol.abf2489","article-title":"Mitochondrial C5aR1 activity in macrophages controls IL-1\u03b2 production underlying sterile inflammation","volume":"6","author":"N Niyonzima","year":"2021","journal-title":"Sci Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.molimm.2016.05.006","article-title":"Differential contribution of complement receptor C5aR in myeloid and non-myeloid cells in chronic ethanol-induced liver injury in mice","volume":"75","author":"R L McCullough","year":"2016","journal-title":"Mol Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.3389\/fimmu.2018.02133","article-title":"Anaphylatoxin receptors C3aR and C5aR1 are important factors that influence the impact of ethanol on the adipose secretome","volume":"9","author":"R L McCullough","year":"2018","journal-title":"Front Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1038\/ncomms10587","article-title":"Structural basis of complement membrane attack complex formation","volume":"7","author":"M Serna","year":"2016","journal-title":"Nat Commun"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"e1900074","DOI":"10.1002\/bies.201900074","article-title":"How the membrane attack complex damages the bacterial cell envelope and kills gram-negative bacteria","volume":"41","author":"D J Doorduijn","year":"2019","journal-title":"BioEssays"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"G66","DOI":"10.1152\/ajpgi.00334.2017","article-title":"Complement factor D protects mice from ethanol-induced inflammation and liver injury","volume":"315","author":"R L McCullough","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molimm.2014.10.017","article-title":"Alternative complement pathway component Factor D contributes to efficient clearance of tissue debris following acute CCl4-induced injury","volume":"64","author":"G A Cresci","year":"2015","journal-title":"Mol Immunol"},{"issue":"12","key":"ref49","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.4049\/jimmunol.2001208","article-title":"Complement receptor 3 forms a compact high-affinity complex with iC3b","volume":"206","author":"R K Jensen","year":"2021","journal-title":"J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1183180","DOI":"10.3389\/fimmu.2023.1183180","article-title":"Efficient complement-mediated clearance of immunosuppressed T cells by macrophages","volume":"14","author":"A AF Gankema","year":"2023","journal-title":"Front Immunol"},{"issue":"05","key":"ref51","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2005.12.039","article-title":"CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens","volume":"124","author":"K Y Helmy","year":"2006","journal-title":"Cell"},{"issue":"07","key":"ref52","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.4049\/jimmunol.1002080","article-title":"Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages","volume":"185","author":"D A Fraser","year":"2010","journal-title":"J Immunol"},{"issue":"06","key":"ref53","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.molimm.2006.06.013","article-title":"Modified low density lipoproteins differentially bind and activate the C1 complex of complement","volume":"44","author":"A Bir\u00f3","year":"2007","journal-title":"Mol Immunol"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4049\/jimmunol.1601445","article-title":"Complement protein C1q enhances macrophage foam cell survival and efferocytosis","volume":"198","author":"M C Pulanco","year":"2017","journal-title":"J Immunol"},{"issue":"12","key":"ref55","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jalz.2017.03.010","article-title":"Peripheral complement interactions with amyloid \u03b2 peptide: erythrocyte clearance mechanisms","volume":"13","author":"W D Brubaker","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1084\/jem.20050189","article-title":"C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation","volume":"201","author":"L A Trouw","year":"2005","journal-title":"J Exp Med"},{"issue":"10","key":"ref57","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4049\/jimmunol.2300333","article-title":"Diverse functions of C4b-binding protein in health and disease","volume":"211","author":"L M Werner","year":"2023","journal-title":"J Immunol"},{"issue":"14","key":"ref58","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.molimm.2011.04.004","article-title":"Complement factor I in health and disease","volume":"48","author":"S C Nilsson","year":"2011","journal-title":"Mol Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1279612","DOI":"10.3389\/fimmu.2023.1279612","article-title":"Functional evaluation of complement factor I variants by immunoassays and SDS-PAGE","volume":"14","author":"A Gerogianni","year":"2023","journal-title":"Front Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fimmu.2019.00493","article-title":"Interaction of serum-derived and internalized C3 with DNA in human B Cells-A potential involvement in regulation of gene transcription","volume":"10","author":"M Kremlitzka","year":"2019","journal-title":"Front Immunol"},{"issue":"05","key":"ref61","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/15548627.2019.1580515","article-title":"Intracellular cytosolic complement component C3 regulates cytoprotective autophagy in pancreatic beta cells by interaction with ATG16L1","volume":"15","author":"B C King","year":"2019","journal-title":"Autophagy"},{"issue":"06","key":"ref62","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.immuni.2015.05.024","article-title":"Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses","volume":"42","author":"M Kolev","year":"2015","journal-title":"Immunity"},{"issue":"06","key":"ref63","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","article-title":"Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation","volume":"39","author":"M K Liszewski","year":"2013","journal-title":"Immunity"},{"issue":"20","key":"ref64","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1182\/blood-2013-05-502229","article-title":"C3a modulates IL-1\u03b2 secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation","volume":"122","author":"E Asgari","year":"2013","journal-title":"Blood"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2018.03.003","article-title":"Intracellular complement activation-an alarm raising mechanism?","volume":"38","author":"M P Reichhardt","year":"2018","journal-title":"Semin Immunol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molimm.2016.02.008","article-title":"Soluble IgM links apoptosis to complement activation in early alcoholic liver disease in mice","volume":"72","author":"R L Smathers","year":"2016","journal-title":"Mol Immunol"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.yexmp.2014.09.004","article-title":"Increased activity of the complement system in the liver of patients with alcoholic hepatitis","volume":"97","author":"H Shen","year":"2014","journal-title":"Exp Mol Pathol"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1038\/s41467-021-27385-3","article-title":"CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease","volume":"12","author":"Y Duan","year":"2021","journal-title":"Nat Commun"},{"issue":"09","key":"ref69","doi-asserted-by":"crossref","first-page":"e174127","DOI":"10.1172\/jci.insight.174127","article-title":"Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis","volume":"9","author":"M Taiwo","year":"2024","journal-title":"JCI Insight"},{"issue":"03","key":"ref70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"W K Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"06","key":"ref71","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"M E Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.semcdb.2017.10.025","article-title":"The complement system is dysfunctional in metabolic disease: evidences in plasma and adipose tissue from obese and insulin resistant subjects","volume":"85","author":"J M Moreno-Navarrete","year":"2019","journal-title":"Semin Cell Dev Biol"},{"issue":"08","key":"ref73","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.4049\/jimmunol.1701668","article-title":"Contribution of adipose-derived factor D\/adipsin to complement alternative pathway activation: lessons from lipodystrophy","volume":"200","author":"X Wu","year":"2018","journal-title":"J Immunol"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"e95478","DOI":"10.1371\/journal.pone.0095478","article-title":"Downregulation of complement C3 and C3aR expression in subcutaneous adipose tissue in obese women","volume":"9","author":"A Gupta","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"ref75","first-page":"e22037","article-title":"Intracellular C3 prevents hepatic steatosis by promoting autophagy and very-low-density lipoprotein secretion","volume":"35","author":"Y Li","year":"2021","journal-title":"FASEB J"},{"issue":"10","key":"ref76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2012.06.001","article-title":"The complotype: dictating risk for inflammation and infection","volume":"33","author":"C L Harris","year":"2012","journal-title":"Trends Immunol"},{"issue":"21","key":"ref77","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.1019338108","article-title":"Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk","volume":"108","author":"M Heurich","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"02","key":"ref78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clim.2013.11.014","article-title":"Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C","volume":"150","author":"M Vasel","year":"2014","journal-title":"Clin Immunol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"110604","DOI":"10.1016\/j.intimp.2023.110604","article-title":"Immunoglobulin A and complement C4 are involved in the progression of liver fibrosis in patients with chronic hepatitis B","volume":"122","author":"X Zhang","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"05","key":"ref80","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/jvh.13810","article-title":"The association of serum immunoglobulin and complement levels and liver fibrosis and inflammation stage in patients with chronic hepatitis B","volume":"30","author":"M Lian","year":"2023","journal-title":"J Viral Hepat"},{"issue":"01","key":"ref81","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s15010-016-0942-7","article-title":"Complement 5a is an indicator of significant fibrosis and earlier cirrhosis in patients chronically infected with hepatitis B virus","volume":"45","author":"Y Deng","year":"2017","journal-title":"Infection"},{"issue":"11","key":"ref82","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1074\/mcp.RA119.001722","article-title":"N-glycopeptide signatures of IgA2 in serum from patients with hepatitis B virus-related liver diseases","volume":"18","author":"S Zhang","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1755-1536-7-9","article-title":"Anaphylatoxin C5a modulates hepatic stellate cell migration","volume":"7","author":"D Das","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"03","key":"ref84","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0002-9440(10)64039-4","article-title":"Plasminogen activators direct reorganization of the liver lobule after acute injury","volume":"158","author":"J A Bezerra","year":"2001","journal-title":"Am J Pathol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"A Forner","year":"2018","journal-title":"Lancet"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"e12031","DOI":"10.1002\/jev2.12031","article-title":"Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells","volume":"10","author":"X Mao","year":"2020","journal-title":"J Extracell Vesicles"},{"issue":"03","key":"ref87","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1002\/iid3.569","article-title":"The role of complement in the clinical course of hepatocellular carcinoma","volume":"10","author":"X Qian","year":"2022","journal-title":"Immun Inflamm Dis"},{"issue":"09","key":"ref88","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.4049\/jimmunol.1201654","article-title":"Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression","volume":"189","author":"L Corrales","year":"2012","journal-title":"J Immunol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3389\/fimmu.2019.00774","article-title":"Complementing the cancer-immunity cycle","volume":"10","author":"R Pio","year":"2019","journal-title":"Front Immunol"},{"issue":"01","key":"ref90","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nri.2017.97","article-title":"Complement in cancer: untangling an intricate relationship","volume":"18","author":"E S Reis","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"ref91","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.leukres.2008.05.014","article-title":"Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab","volume":"32","author":"C S Zent","year":"2008","journal-title":"Leuk Res"},{"issue":"19","key":"ref92","doi-asserted-by":"crossref","first-page":"28013","DOI":"10.18632\/oncotarget.8472","article-title":"Hepatitis B virus X protein up-regulates C4b-binding protein \u03b1 through activating transcription factor Sp1 in protection of hepatoma cells from complement attack","volume":"7","author":"G Feng","year":"2016","journal-title":"Oncotarget"},{"issue":"01","key":"ref93","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13046-024-03047-2","article-title":"Ficolin 3 promotes ferroptosis in HCC by downregulating IR\/SREBP axis-mediated MUFA synthesis","volume":"43","author":"Y Yuan","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"05","key":"ref94","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jcmgh.2021.01.001","article-title":"Complement-5 inhibition deters progression of fulminant hepatitis to acute liver failure in murine models","volume":"11","author":"J Kusakabe","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"380","author":"L Muratori","year":"2023","journal-title":"BMJ"},{"issue":"07","key":"ref96","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lt.22302","article-title":"Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis","volume":"17","author":"I Aguilera","year":"2011","journal-title":"Liver Transpl"},{"issue":"03","key":"ref97","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","author":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu","year":"2021","journal-title":"J Hepatol"},{"issue":"04","key":"ref98","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"D Q Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"03","key":"ref99","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/00365513.2022.2059698","article-title":"Nonalcoholic fatty liver disease and its prognosis associates with shorter leucocyte telomeres in a 21-year follow-up study","volume":"82","author":"A Korkiakoski","year":"2022","journal-title":"Scand J Clin Lab Invest"},{"issue":"02","key":"ref100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3748\/wjg.v29.i2.232","article-title":"Acute-on-chronic liver failure: controversies and consensus","volume":"29","author":"N LY Ngu","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"17","key":"ref101","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"A J Sanyal","year":"2021","journal-title":"N Engl J Med"},{"issue":"06","key":"ref102","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"R S Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0042-1759614","article-title":"Therapeutic pipeline in alcohol-associated liver disease","volume":"43","author":"N Thakral","year":"2023","journal-title":"Semin Liver Dis"},{"issue":"12","key":"ref104","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1002\/hep4.2097","article-title":"Complement complex 1 subunit q-mediated hepatic stellate cell activation with connective tissue growth factor elevation is a prognostic factor for survival in rat and human chronic liver diseases","volume":"6","author":"A Eguchi","year":"2022","journal-title":"Hepatol Commun"},{"issue":"03","key":"ref105","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s12325-022-02416-7","article-title":"Complement C3 facilitates stratification of stages of chronic hepatitis B and signifies development of acute-on-chronic liver failure in acute decompensated cirrhosis","volume":"40","author":"C Chen","year":"2023","journal-title":"Adv Ther"},{"issue":"02","key":"ref106","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/hep.30508","article-title":"The role of complement in liver injury, regeneration, and transplantation","volume":"70","author":"E B Thorgersen","year":"2019","journal-title":"Hepatology"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"E E West","year":"2024","journal-title":"Lancet"},{"issue":"S 01","key":"ref108","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/ijlh.14281","article-title":"Complement inhibition in paroxysmal nocturnal hemoglobinuria: from biology to therapy","volume":"46","author":"F Versino","year":"2024","journal-title":"Int J Lab Hematol"},{"issue":"12","key":"ref109","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood.2023021762","article-title":"Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria","volume":"143","author":"R J Kelly","year":"2024","journal-title":"Blood"},{"issue":"09","key":"ref110","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1016\/S2352-3026(22)00210-1","article-title":"Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial","volume":"9","author":"R P de Latour","year":"2022","journal-title":"Lancet Haematol"},{"issue":"11","key":"ref111","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa2308695","article-title":"Oral iptacopan monotherapy in paroxysmal nocturnal hemoglobinuria","volume":"390","author":"R Peffault de Latour","year":"2024","journal-title":"N Engl J Med"},{"issue":"01","key":"ref112","doi-asserted-by":"crossref","first-page":"e00177-20","DOI":"10.1128\/MMBR.00177-20","article-title":"More than a pore: nonlytic antimicrobial functions of complement and bacterial strategies for evasion","volume":"85","author":"E Bjanes","year":"2021","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"215935","DOI":"10.1016\/j.canlet.2022.215935","article-title":"CD55 in cancer: complementing functions in a non-canonical manner","volume":"551","author":"R Bharti","year":"2022","journal-title":"Cancer Lett"},{"issue":"01","key":"ref114","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.13166","article-title":"The factor H protein family: the switchers of the complement alternative pathway","volume":"313","author":"L Lucientes-Continente","year":"2023","journal-title":"Immunol Rev"},{"issue":"11","key":"ref115","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.4049\/jimmunol.0902388","article-title":"MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation","volume":"183","author":"S E Degn","year":"2009","journal-title":"J Immunol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"g4596","DOI":"10.1136\/bmj.g4596","article-title":"Non-alcoholic fatty liver disease","volume":"349","author":"N Sattar","year":"2014","journal-title":"BMJ"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"c1240","DOI":"10.1136\/bmj.c1240","article-title":"Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies","volume":"340","author":"C L Hart","year":"2010","journal-title":"BMJ"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1795143.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T01:12:59Z","timestamp":1733447579000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1795143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":117,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,12,4]]},"published-print":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1795143","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}